Literature DB >> 26847503

Notch-Induced Expression of FZD7 Requires Noncanonical NOTCH3 Signaling in Human Breast Epithelial Cells.

Vasudeva Bhat1,2, Yu Jia Sun1,2, Steve Weger1,2, Afshin Raouf1,2.   

Abstract

The evolutionarily conserved Notch and Wnt signaling pathways have demonstrated roles in normal mammary gland development and in breast carcinogenesis. We previously reported that in human mammary gland, signaling through NOTCH3 alone regulates the commitment of the undifferentiated bipotential progenitors to the luminal cell fate, indicating that NOTCH3 may regulate the expression of unique genes apart from the other Notch receptors. In this study, we used gain of function and loss of function experiments and found that a Wnt signaling receptor, Frizzled7 (FZD7), is a unique and nonredundant target of NOTCH3 in human breast epithelial cells. Interestingly, neither the constitutively active forms of NOTCH1-2, 4 nor loss of expression of these receptors were able to alter expression of FZD7 in human breast epithelial cells. We further show that FZD7-expressing cells are found more frequently in the luminal progenitor-enriched subpopulation of cells obtained from breast reduction samples compared with the undifferentiated bipotent progenitors. Also, we show that NOTCH3-induced expression of FZD7 occurs in the absence of CSL (CBF1-Suppressor of Hairless-Lag-1). Our data suggest that noncanonical Notch signaling through NOTCH3 could modulate Wnt signaling via FZD7 and in this way, might be involved in luminal cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26847503     DOI: 10.1089/scd.2015.0315

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  7 in total

1.  Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC.

Authors:  Rajeswara Rao Arasada; Konstantin Shilo; Tadaaki Yamada; Jianying Zhang; Seiji Yano; Rashelle Ghanem; Walter Wang; Shinji Takeuchi; Koji Fukuda; Nobuyuki Katakami; Keisuke Tomii; Fumitaka Ogushi; Yasuhiko Nishioka; Tiffany Talabere; Shrilekha Misra; Wenrui Duan; Paolo Fadda; Mohammad A Rahman; Patrick Nana-Sinkam; Jason Evans; Joseph Amann; Elena E Tchekneva; Mikhail M Dikov; David P Carbone
Journal:  Nat Commun       Date:  2018-08-10       Impact factor: 14.919

2.  Inhibitor of DNA Binding 2 Inhibits Epithelial-Mesenchymal Transition via Up-Regulation of Notch3 in Breast Cancer.

Authors:  Xiao-Fen Wen; Min Chen; Yang Wu; Min-Na Chen; Aleksandra Glogowska; Thomas Klonisch; Guo-Jun Zhang
Journal:  Transl Oncol       Date:  2018-08-14       Impact factor: 4.243

3.  Isolation and characterization of a new basal-like luminal progenitor in human breast tissue.

Authors:  Vasudeva Bhat; Victoria Lee-Wing; Pingzhao Hu; Afshin Raouf
Journal:  Stem Cell Res Ther       Date:  2019-08-23       Impact factor: 6.832

4.  PIM-induced phosphorylation of Notch3 promotes breast cancer tumorigenicity in a CSL-independent fashion.

Authors:  Sebastian K J Landor; Niina M Santio; William B Eccleshall; Valeriy M Paramonov; Ellen K Gagliani; Daniel Hall; Shao-Bo Jin; Käthe M Dahlström; Tiina A Salminen; Adolfo Rivero-Müller; Urban Lendahl; Rhett A Kovall; Päivi J Koskinen; Cecilia Sahlgren
Journal:  J Biol Chem       Date:  2021-03-26       Impact factor: 5.157

5.  Syndecan-3 enhances anabolic bone formation through WNT signaling.

Authors:  Francesca Manuela Johnson de Sousa Brito; Andrew Butcher; Addolorata Pisconti; Blandine Poulet; Amanda Prior; Gemma Charlesworth; Catherine Sperinck; Michele Scotto di Mase; Ke Liu; George Bou-Gharios; Robert Jurgen van 't Hof; Anna Daroszewska
Journal:  FASEB J       Date:  2021-04       Impact factor: 5.191

Review 6.  Frizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat Cancer.

Authors:  Toby Phesse; Dustin Flanagan; Elizabeth Vincan
Journal:  Cancers (Basel)       Date:  2016-05-17       Impact factor: 6.639

7.  Notch3 inhibits epithelial-mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression.

Authors:  Hao-Yu Lin; Yuan-Ke Liang; Xiao-Wei Dou; Chun-Fa Chen; Xiao-Long Wei; Jing-Wen Bai; Yu-Xian Guo; Fang-Fang Lin; Wen-He Huang; Cai-Wen Du; Yao-Chen Li; Min Chen; Guo-Jun Zhang
Journal:  Oncogenesis       Date:  2018-08-13       Impact factor: 7.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.